SCHEMBL845289

SCHEMBL845289

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3ccccc3F)cc2)cc1)[C@@H]1CCCN1C(=O)Cc1ccccc1F

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
TSHR P16473 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HCRTR1 O43613 2/20 0.45
HCRTR2 O43614 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
TACR1 P25103 1/20 0.44
PABPC1 P11940 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
CFD P00746 2/20 0.44
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845311 0.86 NTMT1 (0.54) ALDH1A1CYP2C9CYP2C19HCRTR1HCRTR2
SCHEMBL845618 0.85 MAPK1 (0.56) ALDH1A1TDP1CYP2C9CYP2C19SMN1; SMN2
SCHEMBL845111 0.85 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19HCRTR1HCRTR2
SCHEMBL1030175 0.85 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19HCRTR1HCRTR2
SCHEMBL13272444 0.85 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19HCRTR1HCRTR2
SCHEMBL845226 0.85 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19HCRTR1HCRTR2
SCHEMBL845205 0.85 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19HCRTR1HCRTR2
SCHEMBL15116912 0.85 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19HCRTR1HCRTR2
SCHEMBL845567 0.84 ALDH1A1 (0.50) ALDH1A1CYP2C9CYP2C19HCRTR1HCRTR2
SCHEMBL845305 0.83 GAA (0.58) ALDH1A1TSHRTDP1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed